Heron Therapeutics Receives Complete Response Letter for HTX-011 for the Management of Postoperative Pain

Go back to Heron Therapeutics Receives Complete Response Letter for HTX-011 for the Management of Postoperative Pain
HERON THERAPEUTICS (NASDAQ: HRTX) Delayed: 0.36 --0 (-0%)
Previous Close $0.36    52 Week High $31.32 
Open $0.36    52 Week Low $13.95 
Day High $0.36    P/E N/A 
Day Low $0.36    EPS $-3.29 
Volume 561